IDH1 and endometrial cancer: Our results revealed that MPA, in combination with focal adhesion inhibitors or p38 inhibitor markedly induced apoptosis in endometrial cancer cells (Figure 8b), suggesting the suppression of focal adhesions or IDH1 phosphorylation improved MPA efficacy.